279 results on '"Seidman, E G"'
Search Results
2. Recent developments in the diagnosis and management of paediatric inflammatory bowel disease
3. Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohnʼs disease
4. Review article: a clinicianʼs guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
5. Susceptibility loci reported in genome-wide association studies are associated with Crohnʼs disease in Canadian children
6. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohnʼs disease
7. Mannan-binding lectin in children with Escherichia coli O157: H7 haemmorrhagic colitis and haemolytic uraemic syndrome
8. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease
9. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway
10. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α
11. The effect of inflammation severity and of treatment on the production and release of TNFα by colonic explants in inflammatory bowel disease
12. Dexamethasone inhibits IFNγ-induced MHC class II expression of intestinal epithelial cells independently of the TGF-β1 regulatory pathway
13. A134 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE. RESULTS FROM A TERTIARY IBD CENTER.
14. A105 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE. RESULTS FROM A TERTIARY IBD CENTER.
15. A78 IMPACT OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH-VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESSIBILITY, REASOURCE UTILISATION AND OUTCOMES
16. A260 HEALTH-RELATED QUALITY OF LIFE IMPACT OF STEROIDS VS. EXCLUSIVE ENTERAL NUTRITION FOR INDUCTION IN A LARGE CANADIAN PEDIATRIC IBD INCEPTION COHORT
17. A112 HARMONIZATION OF QUALITY OF CARE IN AN IBD CENTER IMPACTS DISEASE OUTCOMES: IMPORTANCE OF STRUCTURE AND PROCESS INDICATORS
18. Co-screening for primary biliary cirrhosis and coeliac disease: 6-Mercaptopurine metabolism in Crohn's disease: Reply
19. Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD)
20. Quantitative PCR Analysis of TNF-α and IL-1β mRNA Levels in Pediatric IBD Mucosal Biopsies
21. Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohnʼs disease patients on maintenance 6-mercaptopurine therapy
22. Distinct patterns of cow's milk allergy in infancy defined by prolonged, two-stage double-blind, placebo-controlled food challenges
23. A155 QUALITY OF CARE IN THE INFLAMMATORY BOWEL DISEASES (IBD) CENTER FROM A TERTIARY REFERRAL HOSPITAL: PATIENT ASSESSMENT STRATEGY AT REFERRAL
24. A153 QUALITY OF CARE AND OUTCOMES IN A TERTIARY HOSPITAL INFLAMMATORY BOWEL (IBD) CENTER: MONITORING AND TREATMENT ALGORITHMS DURING FOLLOW-UP
25. A103 PHENOTYPIC VARIATION IN PEDIATRIC IBD BY AGE: A MULTI-CENTRE INCEPTION COHORT STUDY OF THE CANADIAN CHILDREN IBD NETWORK
26. A30 ETHNIC VARIATION OF PEDIATRIC INFLAMMATORY BOWEL DISEASE IN CANADA
27. A17 LINEAR GROWTH IMPAIRMENT IN CANADIAN CHILDREN PRESENTING WITH NEW ONSET IBD: A MULTI-CENTRE INCEPTION COHORT STUDY
28. A154 BENEFITS OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESSIBILITY, RESOURCE UTILIZATION AND OUTCOMES
29. Immunolocalization, ontogeny, and regulation of microsomal triglyceride transfer protein in human fetal intestine
30. Gene expression profiling in necrotizing enterocolitis reveals pathways common to those reported in Crohn's disease
31. Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease
32. Nutritional therapy of Crohn's disease in childhood
33. Pediatric Findings
34. Swallowing and Motility Disorders, Pacemakers, and Obesity
35. Eosinophilic Enteritis
36. Antibody screening for celiac disease
37. Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease
38. Effectiveness of antigliadin antibodies as a screening test for celiac disease in children
39. Mechanisms of hypercholesterolaemia in glycogen storage disease type I: defective metabolism of low density lipoprotein in cultured skin fibroblasts
40. No evidence of persisting measles virus in the intestinal tissues of patients with inflammatory bowel disease
41. Liver transplantation for hereditary tyrosinemia: the Quebec experience
42. Capsule Endoscopy 2005: Results of the 2005 International Consensus Conference - Introduction
43. O0076 ROLE OF THE SMALL INTESTINE IN DYSLIPIDEMIA DURING THE DEVELOPMENT OF INSULIN RESISTANCE IN PSAMMAMYS OBESUS
44. P0501 AN ASSAY FOR INTRACELLULAR TH1/TH2 CYTOKINE MEASUREMENT IN WHOLE BLOOD FOR FOOD PROTEIN HYPERSENSITIVITY
45. P0170 PP DEVELOPMENTAL AND FUNCTIONAL CHARACTERISTICS OF SR‐BI IN THE HUMAN INTESTINE
46. P0357 SR-BI AND ABC1 ARE TWO KEY PLAYERS IN CHOLESTEROL HOMEOSTASIS IN BILE DUCT CELLS
47. O0072 6-MMP/6-TG METABOLITE LEVELS & THEIR RATIO GUIDE THIOPURINE TREATMENT IN ULCERATIVE COLITIS
48. P0722 COPING AND RESILIENCE IN PEDIATRIC CROHN’S DISEASE
49. P0133 PP CAPSULE ENDOSCOPY REVEALS SMALL BOWEL INFLAMMATORY LESIONS OF “OCCULT” CROHN’S DISEASE AND EOSINOPHILIC ENTERITIS
50. Mannan-binding lectin in children with Escherichia coli O157:H7 haemmorrhagic colitis and haemolytic uraemic syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.